Literature DB >> 1595122

Thrombotic thrombocytopenic purpura associated with ticlopidine.

E Ellie, C Durrieu, P Besse, J Julien, G Gbipki-Benissan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1595122     DOI： 10.1161/01.str.23.6.922

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

2.  [Thrombotic thrombocytopenic purpura (Moschkowitz-syndrome) caused by ticlopidine].

Authors:  J M Chemnitz; A Schulz; A Salameh; C Scheid; R Müller; A Draube; V Diehl; D Söhngen
Journal:  Med Klin (Munich)       Date:  2000-02-15

3.  [Ticlopidine-associated thrombotic thrombocytopenic purpura (Morbus Moschcowitz)].

Authors:  J Carlsson; S Miketic; R Bätge; P Riedel; G Rahlf; U Tebbe
Journal:  Med Klin (Munich)       Date:  2000-01-15

Review 4.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 5.  Adverse haematological effects of ticlopidine. Prevention, recognition and management.

Authors:  B B Love; J Biller; M Gent
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

6.  Ticlopidine hydrochloride use and threatened stroke.

Authors:  J F Rothrock; R G Hart
Journal:  West J Med       Date:  1994-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.